Visit our comprehensive poster gallery!

ORGANIZED BY:

IN COLLABORATION WITH:

DESTINATION PARTNER:

ORGANIZED BY:
World Federation of Hemophilia

IN COLLABORATION WITH:
HEMNET
ESH

DESTINATION PARTNER:
Dubai

Abstracts

WFH 2025 Comprehensive Care Summit
[email protected]

ORGANIZED BY:
World Federation of Hemophilia

IN COLLABORATION WITH:
HEMNET
ESH

DESTINATION PARTNER:
Dubai

Join us at the WFH 2025 Comprehensive Care Summit: New Developments in Bleeding Disorders and MSK, which will take place from April 23 to 25, 2025, in the vibrant city of Dubai, U.A.E. This global event will feature specialized tracks for MSK, medical professionals, and people with bleeding disorders, bringing together experts, patients, and advocates from around the world. This global summit is open to all participants.

HAEMOPHILIA SUPPLEMENTS

CCS 2025 Invited Medical Presentation Abstracts

Delve into the official collection of abstracts and visual synopses from the Medical Track sessions at the WFH 2025 CCS. This collection features expert-led presentations on topics such as optimal therapies for hemophilia A and B, surgical management in bleeding disorders, and rare bleeding disorders, among many others.


CCS 2025 Book of Abstracts

Explore the CCS 2025 Book of Abstracts, encompassing all poster and free paper presentations from the WFH 2025 CCS. This compilation highlights innovative research and clinical advancements in bleeding disorders and musculoskeletal care, offering a comprehensive overview of the summit’s contributions.

ABSTRACTS AND POSTERS

The World Federation of Hemophilia (WFH) is thrilled to announce that five new free paper sessions have been added to the WFH 2025 Comprehensive Care Summit! These sessions will feature top-scoring abstracts from leading experts, covering groundbreaking research in clinical trials, orthopedic issues, novel therapies, and more.

With a record number of abstract submissions this year, we’ve expanded our free paper sessions beyond what we offered in 2023, alongside 150+ posters displayed in our in-person and virtual poster galleries—giving even more researchers a platform to share their innovative work. For more information on our free paper sessions, please visit our full program.

The WFH would like to thank our expert Abstract Review Committee for the time they took to review the 2025 abstract submissions. Their contribution in the impartial review process has allowed the WFH to maintain a high level of quality for the WFH 2025 Comprehensive Care Summit.

The Abstract Review Committee for the WFH 2025 Comprehensive Care Summit is composed of accomplished professionals representing a broad range of specialty areas and scientific approaches.

Christian Carulli, Italy

Erica Crilly, Canada

Carla Daffunchio, Argentina

Rohini Dange, India

Antonio Gavrilovski, Macedonia

Emna Gouider, Tunisia

Silvina Grana, Argentina

Cedric Hermans, Belgium

Paula James, Canada

Kate Khair, United Kingdom

Claudia Khayat, Lebanon

Barbara Konkle, USA

Johnny Mahlangu, South Africa

Mike Makris, United Kingdom

Maria Elisa Mancuso, Italy

Tadashi Matsushita, Japan

William McKeown, Northern Ireland

Paul McLaughlin, United Kingdom

Mohsena Olath, Mauritius

David Page, Canada

Steve Pipe, USA

Hortensia de la Corte Rodriguez, Spain

Thomas Sannié, France

Roger Schutgens, Netherlands

Robert Sidonio, USA

Mauricio Silva, USA

Mark Skinner, USA

Alok Srivastava, India

KEY DATES
Deadline to submit poster April 11, 2025
Deadline to submit PowerPoint slides for free paper presentations April 20, 2025

Presenting authors should download and carefully read the following guidelines prior to preparing and submitting their poster and/or presentation.

Haemophilia journal

All abstracts published in Haemophilia, will be publicly released at 9:00 a.m. CEST on April 23, 2025, and will be made available online.

Questions? Contact us at [email protected].

CALL FOR ABSTRACTS

The call for abstracts is now closed. Thank you to all who submitted!

The 2025 program will cover the latest developments and innovations in our field, from healthcare issues to the challenges ahead for the management and treatment of hemophilia, von Willebrand disease (VWD), rare factor deficiencies, and inherited platelet disorders. This aspect of the summit—of bringing the best and brightest in our field together in one place—is critical to foster new ideas and approaches in our field.

KEY DATES
Call for abstracts opensOctober 15, 2024
Abstract submission deadline

December 15, 2024, 11:59 p.m. ET

Notification to authorsJanuary 20, 2025
Presenting author registration deadlineJanuary 31, 2025

WHY SUBMIT TO THE WFH COMPREHENSIVE CARE SUMMIT?

The summit will feature specialized tracks for MSK, medical professionals, and people with bleeding disorders, bringing together experts, patients, and advocates from around the world. Presenting authors can expect to share their work with top experts and researchers from around the world.

Selected abstracts may be eligible for:

Publication in Haemophilia, the official journal of the WFH
Oral presentation in a free paper session
Printed poster and presentation during dedicated breaks
Christine Lee Young Researcher Award for best oral presentation (all disciplines)
Henri Horoszowski Award for best-scoring abstract (musculoskeletal track only)

We look forward to seeing you in Dubai!

Submit an abstract

Submit your work today and join thousands of leading experts who are contributing to the latest advances in the treatment and care of people with bleeding disorders. To find out more about Haemophilia, the official journal of the WFH, please click here.

Questions? Contact us at [email protected].

HOW TO SUBMIT AN ABSTRACT

Before submitting, please make sure to carefully read the abstract submission guidelines.

To submit your abstract

Step 1: Create your profile and login to access the Abstract Scorecard

Step 2: Complete all the tasks to submit your abstract

Step 3: Once completed, be sure to click submit

Editing a submission

You may edit your abstract after submitting it, up to the submission deadline of December 15, 2024.

To edit your abstract, log in to the Abstract Scorecard site to access your submission(s), where you will be able to make edits and changes.

Important notes:

Abstracts should only be submitted through the online system. Abstracts sent via post or email will not be considered.
Only abstracts which have been submitted properly will be considered. Incomplete abstracts will be automatically rejected.
Abstracts will only be accepted in English. Abstracts submitted in other languages will automatically be rejected.

AWARDS

Christine Lee Young Researcher Award

All disciplines (Medical, PWBD, MSK)

Established in 2012 by the WFH and Wiley, the Christine Lee Young Researcher Award (formerly the Christine Lee Haemophilia Journal Award) is given in recognition to a top young researcher (graduate student or postdoctoral fellow) who is the primary author and presenter of a highly rated submitted abstract in any discipline involving hemophilia or other related bleeding disorders.

Congratulations to our 2025 winner:

Ilenia Calcaterra
Italy
Intensive FVIII replacement in haemophilia patients with hypertrophic synovium: a randomized study


Best oral presentation

A prize of 3,000 USD and a three-year online personal subscription to Haemophilia, the official journal of the WFH, is provided for this award.

Eligibility

The selection committee—including the Journal’s editors and WFH representatives on the Editorial Board—will choose the best presented abstracts at the WFH 2025 CCS. There will be one recipient per prize.

The young researcher must be under the age of 40 at the time the abstract is submitted. If there are multiple authors, the lead author and presenter must be under the age of 40 at the time the abstract is submitted.

To find out more about the Christine Lee Young Researcher Award, click here. To find out more about Haemophilia, the official journal of the WFH, please click here.

Henri Horoszowski Award

Musculoskeletal field only

This award was established in 1998 to honour the memory of Professor Henri Horoszowski, former chairperson of the Musculoskeletal Committee, and to encourage musculoskeletal specialists to become involved in hemophilia care.

Congratulations to our 2025 winner:

Shubhranshu S. Mohanty
India
Haemophilic pseudotumour - New improvised classification system and its outcome in 168 cases at a Tertiary care centre

The presenters of any free paper in the musculoskeletal field selected for inclusion in the CCS 2025 are eligible for the award, with two exceptions:

  • Current or past members of the Musculoskeletal Committee
  • Previous winners of the award

Criteria for the award include scientific methodology, originality, relevance, and quality of the presentation as determined by a panel of judges appointed by the Musculoskeletal Executive Committee.

To find out more about the Henri Horoszowski Award, click here. To find out more about Haemophilia, the official journal of the WFH, please click here.

ABSTRACTS FAQ

Q
How long should my abstract be?
A

Your abstract should be no longer than 350 words. This does not include the author’s details, titles, tables and graphs.

Q
Can I include tables/graphs in my abstract?
A

A maximum of two tables and/or graphs can be included in an abstract. Please make sure to add headings to each of the tables and/or graphs, and to reference them within the abstract. Please do NOT include the author list on the figure/table you are uploading, as we operate by blind review.

Q
How many abstracts can I submit?
A

There is no limit on the number of abstracts a single author can submit.

Q
How many abstracts can I present?
A

Each presenting author may present a maximum of two abstracts at CCS. Should an author have more than two abstracts accepted, a co-author must be named as the presenting author for the third or more abstracts.

Q
Can I submit my abstract by email?
A

No. Abstracts should only be submitted through the online submission system. Abstracts sent via email will not be accepted.

Q
Can I submit an abstract in a language other than English?
A

No. Abstracts will only be accepted in written English. Abstracts submitted in any language other than English will be automatically rejected.

Q
How many authors can be listed for each submission?
A

A maximum of 20 authors is permitted on each abstract.

Q
Can I edit/make changes to my abstract?
A

Corrections can be made until the submission deadline of December 15, 2024. To ensure the integrity of the review process, no revisions will be allowed after the abstract submission deadline.

Q
Can I submit an abstract if I have presented it at another scientific meeting or submitted it to a journal?
A

Yes, encore presentations will be accepted. Encore abstracts should not be an exact duplicate of a previously presented abstract. Encore presentations will be considered for oral or poster presentations. They will not be published in the Haemophilia supplement.

Q
Can I submit a trial-in-progress abstract?
A

Yes. The WFH is accepting trials-in-progress abstracts. Please consult the abstract submission guidelines for details.

Q
Can an administrator/third party submit an abstract on behalf of the authors?
A

Yes. However, note that if the abstract is accepted, all subsequent notifications and correspondence will be addressed to the presenting author.

Q
When will I know if my abstract has been accepted?
A

You will be notified no later than January 20, 2025.

Q
Do I need to register to attend CCS?
A

Yes. All presenting authors must register to attend CCS by January 31, 2025. After this date, presenting authors who have not registered and paid their registration fees will be excluded from the program as well as from the Haemophilia journal publication. Registration fees will not be waived.

Q
Can I present virtually?
A

No. CCS 2025 will take place in-person only. Presenting authors will therefore be required to be onsite in Dubai, U.A.E.

Q
When will my accepted abstract be published?
A

Abstracts selected for publication will be made available on the website of Haemophilia by April 23, 2025. The publication will be available on the Wiley website, the WFH CCS website, and the CCS mobile app.

Q
Will the WFH be accepting late-breaking abstracts?
A

No. There will not be a call for late-breaking abstracts for CCS 2025.

Q
Is my submission subject to embargo? If so, when does the embargo lift?
A

All abstracts will be publicly released at 9:00 a.m. CEST on April 23, 2025, and will be made available online.

Do you have additional questions? Please contact us at [email protected].

Thank you for subscribing!

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.